Back to mobile site

Pacira Pharmaceuticals (PCRX) PT Raised to $36.50 at RBC Capital

October 8, 2026 2:09 PM EDT Send to a Friend
RBC Capital analyst Gregory Renza ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login